Cargando…
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
ABSTRACT: In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI), gadopentetate dimeglumine (Magnevist(®)), became available for clinical use. Since then, a plethora of studies have investigated the potential of MRI contrast agents for diagnostic imaging across...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735235/ https://www.ncbi.nlm.nih.gov/pubmed/26809251 http://dx.doi.org/10.1007/s12325-015-0275-4 |